-
Avid Names Richard Hancock Interim President & CEO
contractpharma
May 21, 2019
Industry veteran with over 30 years of operational and executive experience succeeds Roger Lias.
-
Sekisui Invests $1.9M in Microbial Biopharma CDMO Business
contractpharma
May 17, 2019
New BioProcess Innovation Center in UK will be operational by the end of 2019.
-
Micro-Sphere Partners With PTM Consulting
contractpharma
May 16, 2019
Will offer customers support across the entire drug product development and manufacturing cycle.
-
LSNE Receives GMP Certification by Brazil's ANVISA
contractpharma
May 16, 2019
Marks the first LSNE manufacturing facility to receive ANVISA certification.
-
Custom to build £20 million Pharmaceutical Innovation Centre in Brighton
europeanpharmaceuticalreview
May 08, 2019
Custom to build £20 million Pharmaceutical Innovation Centre in Brighton.
-
Aesica adds development capability with new purpose built facility
europeanpharmaceuticalreview
May 07, 2019
Product life cycle services expanded, including for high potent and controlled drugs…
-
Chinese CDMO GenScript Breaks Ground
contractpharma
April 24, 2019
GenScript Biotech, a Chinese biopharmaceutical contract development and manufacturing organization (CDMO), held the groundbreaking ceremony for the start of construction of the GenScript-Legend Biotech Commercial Manufacturing Center.
-
China's GenScript starts on plasmid, virus making facility
fiercepharma
April 22, 2019
Chinese CDMO GenScript Biotech already has a deal to produce a CAR-T drug being developed by its Legend Biotech unit and Janssen.
-
Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville
pharmafocusasia
April 19, 2019
Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville.
-
Biotechpharma to expand process development and GMP manufacturing capacity to 5,000 L
europeanpharmaceuticalreview
April 19, 2019
Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors.